A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients
Abstract
Over 3 months, 13 Caucasian and 16 Asian schizophrenic patients were sequentially treated with weight-adjusted fixed doses and clinically determined, variable doses of haloperidol. During the fixed-dose phase, Asians had a slightly higher mean serum haloperidol concentration and a significantly higher rating for extrapyramidal symptoms. During the variable-dose phase, the Asian patients' mean required dose was significantly lower, resulting in lower serum haloperidol concentrations at the first emergence of extrapyramidal symptoms and for optimal clinical response. These results indicate pharmacodynamic differences in therapeutic response but no significant difference in steady-state serum concentration between the two groups.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).